Matošević, A.; Opsenica, D.M.; Bartolić, M.; Maraković, N.; Stoilković, A.; Komatović, K.; Zandona, A.; Žunec, S.; Bosak, A.
Derivatives of Amodiaquine as Potent Human Cholinesterases Inhibitors: Implication for Treatment of Alzheimer’s Disease. Molecules 2024, 29, 5357.
https://doi.org/10.3390/molecules29225357
AMA Style
Matošević A, Opsenica DM, Bartolić M, Maraković N, Stoilković A, Komatović K, Zandona A, Žunec S, Bosak A.
Derivatives of Amodiaquine as Potent Human Cholinesterases Inhibitors: Implication for Treatment of Alzheimer’s Disease. Molecules. 2024; 29(22):5357.
https://doi.org/10.3390/molecules29225357
Chicago/Turabian Style
Matošević, Ana, Dejan M. Opsenica, Marija Bartolić, Nikola Maraković, Andriana Stoilković, Katarina Komatović, Antonio Zandona, Suzana Žunec, and Anita Bosak.
2024. "Derivatives of Amodiaquine as Potent Human Cholinesterases Inhibitors: Implication for Treatment of Alzheimer’s Disease" Molecules 29, no. 22: 5357.
https://doi.org/10.3390/molecules29225357
APA Style
Matošević, A., Opsenica, D. M., Bartolić, M., Maraković, N., Stoilković, A., Komatović, K., Zandona, A., Žunec, S., & Bosak, A.
(2024). Derivatives of Amodiaquine as Potent Human Cholinesterases Inhibitors: Implication for Treatment of Alzheimer’s Disease. Molecules, 29(22), 5357.
https://doi.org/10.3390/molecules29225357